# Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis

> **NCT03085940** · NA · COMPLETED · sponsor: **Indonesia University** · enrollment: 37 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03085940
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-20
- **Primary completion:** 2017-09-30
- **Final completion:** 2017-09-30
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085940, "Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03085940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*